Back to Search
GARY GIBLIN, MD
MD
Family Medicine Physician
NPI: 1396733283IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
95243(NM)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
PMID 19332369·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
PMID 19036582·Bioorg Med Chem Lett·2009
7-preclinical
Pyridine-3-carboxamides as novel CB(2) agonists for analgesia.
PMID 19010671·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
PMID 18571922·Bioorg Med Chem Lett·2008
8-other
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
PMID 18462938·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
PMID 18378447·Bioorg Med Chem Lett·2008
7-preclinical
Novel methylene-linked heterocyclic EP1 receptor antagonists.
PMID 18262416·Bioorg Med Chem Lett·2008
8-other
EP1 antagonists for the treatment of inflammatory pain.
PMID 17786859·Curr Opin Drug Discov Devel·2007
6-review
Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists.
PMID 17574410·Bioorg Med Chem Lett·2007
8-other
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.
PMID 17477516·J Med Chem·2007
7-preclinical
Identification of novel glycine sulfonamide antagonists for the EP1 receptor.
PMID 17236765·Bioorg Med Chem Lett·2007
7-preclinical
Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists.
PMID 17196385·Bioorg Med Chem Lett·2007
8-other
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
PMID 17175160·Bioorg Med Chem Lett·2007
7-preclinical
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
PMID 17098427·Bioorg Med Chem Lett·2007
7-preclinical
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
PMID 17084082·Bioorg Med Chem Lett·2007
7-preclinical
Identification of novel pyrazole acid antagonists for the EP1 receptor.
PMID 16843659·Bioorg Med Chem Lett·2006
7-preclinical
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
PMID 16697196·Bioorg Med Chem Lett·2006
7-preclinical
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
PMID 16604093·Br J Pharmacol·2006
7-preclinical
Discovery of novel biaryl heterocyclic EP1 receptor antagonists.
PMID 16503138·Bioorg Med Chem Lett·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2145 CAJA DEL ORO GRANT RD
SANTA FE, NM 87507 - Phone
- (505) 438-3195
Quick Facts
- NPI
- 1396733283
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile